In addition, the dysregulation of NF-κB and the related signaling pathways is also shown to play a major role in modulating cancer therapy efficacy, by promoting resistance to chemotherapy as well as radiotherapy [172,173]. The gene discussed is NFKB1; the disease is cancer.